Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Management / 管理學院
  3. International Business / 國際企業學系
  4. Business Model Analysis of Biotechnology and Medical Companies in Taiwan
 
  • Details

Business Model Analysis of Biotechnology and Medical Companies in Taiwan

Date Issued
2004
Date
2004
Author(s)
Chen, Mei-Ju
DOI
zh-TW
URI
http://ntur.lib.ntu.edu.tw//handle/246246/60380
Abstract
Under the favorable policy support and a well-established legal environment, the biotechnology and medical industry in developed countries prosper with vigorous market growth and leading technologies. In the past, only few very large pharmaceutical companies were able to finish the whole process of new drug research and development on their own. In contrast, the trend is towards specialization in a particular section of the value chain. The specialization allows small biotech companies to focus on and leverage their core competences through strategic alliances and interdependency. This development provides opportunities for companies in Taiwan with constrained endowments to go across the territory of new drug development. The biotechnology and medical industry in Taiwan faces critical limits in technology and resources. Under such circumstances, how do these biotech and pharmaceutical companies organize their scarce capital assets, construct their business model to strengthen core competences, avoid business risk, cooperate with foreign companies, and eventually enter the new drug development field? We also want to find out which kind of business model is more suitable under Taiwan’s situation (both on a macro and micro level). In order to fully understand the operating models in the stages of growth, we choose Vita, Genovate, Maywufa and TTY as our research targets, and combine with related business model theories to analyze Taiwan’s medical industry and companies’ business models (business scope, profit capture, value proposition, strategy control), cooperative models, and growth paths. The conclusion will set forth the conditions and limits that different models will confront, thus providing a reference for incumbents and new entrants.
Subjects
經營模式
懷特新藥
賽亞基因
健亞生技
價值鏈
Vita
Genovate
Value Chain
TTY
Business Model
Maywufa
Type
thesis
File(s)
Loading...
Thumbnail Image
Name

ntu-93-R91724068-1.pdf

Size

23.31 KB

Format

Adobe PDF

Checksum

(MD5):00ff394ca975bb06c48371a437a6a237

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science